Towards Healthcare
Propofol Injection Market to Grow at 7.14% CAGR till 2034

Propofol Injection Market Surges Amid Hospital Demand

Market insights predict the global propofol injection industry will increase from USD 1.34 billion in 2024 to USD 2.64 billion by 2034, achieving a CAGR of 7.14%. The increasing number of surgeries and growing research and development activities drive the global market. North America dominated the market due to a robust healthcare infrastructure and favorable reimbursement policies.

Content

  • Last Updated: 29 October 2025
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2023
  • Base Year: 2024
  • Estimated Years: 2025-2034

About The Author

Deepa Pandey is a focused and detail-oriented market research professional with growing expertise in the healthcare sector, delivering high-quality insights across therapeutic areas, diagnostics, biotechnology, and healthcare services.

She began her research career at Precedence Research, where she contributed to a wide range of healthcare industry studies, helping build a strong foundation in market intelligence and strategic research. Currently, Deepa plays a critical role at Towards Healthcare, while also extending her research capabilities across Statifacts, supporting cross-industry intelligence initiatives with a focus on healthcare.

Her ability to distill complexity into clarity has made her a trusted contributor to both internal teams and external clients across the healthcare value chain. By combining professionalism with an evolving depth in healthcare research, Deepa consistently adds value to projects that demand critical thinking, market precision, and industry-specific knowledge. Her contributions help organizations navigate the complexities of regulated markets and make data-backed growth decisions.

Talk to us
FAQ's

The propofol injection market in 2025 is valued at USD 1.43 billion and is projected to climb to USD 2.64 billion by 2034, with a CAGR of 7.14% over the forecast period.

North America is leading the propofol injection market share by 40% due to the availability of a robust healthcare infrastructure and the increasing adoption of advanced technologies.

The propofol injection market includes 6 segments by formulation type, by application, by concentration, by end-user, by distribution channel, and by region.

Some key players include Fresenius Kabi AG, Hikma Pharmaceuticals LLC, and Sichuan Guorui Pharmaceutical Co., Ltd.

Propofol toxicity leads to hypertriglyceridemia, metabolic acidosis, cardiac failure, and rhabdomyolysis.

National Institute of Health, Food and Drug Administration, American Hospital Association, clinicaltrials.gov
Any Questions